S. Akgün, Sibel Tunç Karaman, Sonay Özdemir, O. Basat
{"title":"Evaluation of Oral Anticoagulant Usage Satisfaction in Home Care Patients Using Warfarin","authors":"S. Akgün, Sibel Tunç Karaman, Sonay Özdemir, O. Basat","doi":"10.4274/JAREM.GALENOS.2021.3732","DOIUrl":null,"url":null,"abstract":"Results: The ages of 97 patients included in the study ranged from 19 to 92 years; moreover, 71.1% (n=69) of the patients were women. In total, 41.2% (n=40) of the patients have had haemorrhagic events during the use of warfarin. The DASS mean score of the patients was 57.67±14.56, 20.46±5.89 for the limitations with the treatment, 21.54±7.46 for the hassles and burdens, and 15.67±4.87 for the positive impacts. It was determined that the number of additional chronic diseases and bleeding conditions while using warfarin had a significant effect on the total score and subscale scores of DASS (for total score, p=0.046; for subscale scores, p<0.001) and reduced satisfaction.","PeriodicalId":56162,"journal":{"name":"Journal of Academic Research in Medicine-JAREM","volume":"11 1","pages":"38-45"},"PeriodicalIF":0.1000,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Academic Research in Medicine-JAREM","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/JAREM.GALENOS.2021.3732","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Results: The ages of 97 patients included in the study ranged from 19 to 92 years; moreover, 71.1% (n=69) of the patients were women. In total, 41.2% (n=40) of the patients have had haemorrhagic events during the use of warfarin. The DASS mean score of the patients was 57.67±14.56, 20.46±5.89 for the limitations with the treatment, 21.54±7.46 for the hassles and burdens, and 15.67±4.87 for the positive impacts. It was determined that the number of additional chronic diseases and bleeding conditions while using warfarin had a significant effect on the total score and subscale scores of DASS (for total score, p=0.046; for subscale scores, p<0.001) and reduced satisfaction.